Skip to main content
INOVIQ LTD logo

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2024-06-11 Capital/Financing Update
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
INOVIQ completes $7m placement 6 pages 291.4KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 12 June 2024 regarding a capital raising by INOVIQ Limited. It details a placement of shares and a share purchase plan (SPP) to raise approximately A$7 million plus up to A$2 million via SPP. The announcement includes specifics on the offer price, use of funds, timetable, and participation by board and management. It is focused on fundraising activities and capital structure changes, with no financial statements or earnings data presented. The document is lengthy (15,000 characters) and contains detailed information about the capital raising but is not a financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP).
2024-06-11 English
Investor Presentation 38 pages 2.1MB
Investor Presentation Classification · 95% confidence The document is titled 'Investor update June 2024' and contains detailed information about the company's technologies, financial data, market position, and strategic focus. It includes disclaimers typical of investor presentations, such as forward-looking statements, non-IFRS financial measures, and investment risk warnings. The document references a proposed placement of new shares and options, indicating a capital raising context. The length is about 15,000 characters, indicating a substantial presentation rather than a brief announcement. There is no indication that this is a full annual or interim report, audit report, or earnings release. The content and format align with an investor presentation focused on financials, strategy, and market position rather than regulatory filings or voting results. Therefore, the document best fits the category of an Investor Presentation (IP).
2024-06-11 English
INOVIQ isolates brain-derived exosomes in Alzheimer's 2 pages 286.0KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 12 June 2024 from INOVIQ Limited. It discusses the expansion of their NEURO-NET technology to isolate brain-derived exosomes for Alzheimer's Disease. The content focuses on the technology's capabilities, validation studies, and potential applications in diagnostics and therapeutics. There are no financial statements, regulatory certifications, voting results, or management changes reported. The document is a corporate announcement about a product development and scientific validation, typical of a Capital/Financing Update or general company update. Given the nature of the announcement and the absence of financial results or regulatory filings, the best fitting category is Capital/Financing Update (CAP), as it relates to company technology advancement and potential collaborations that could impact financing or capital structure in the future. The document length (5764 characters) and detailed content support this classification with high confidence.
2024-06-11 English
Proposed issue of securities - IIQ 12 pages 36.8KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and contains detailed information about a proposed issue of securities by INOVIQ LTD, including the number and type of securities, offer price, record date, issue date, and conditions of the offer. It references ASX Listing Rules and provides specifics about a securities purchase plan and a placement. The content is focused on the announcement of a new share issue and related securities, including options and ordinary shares. There are no financial statements or performance data, nor is this a report or presentation. The document is a formal announcement of a capital raising event and securities issuance, which fits the definition of a Capital/Financing Update (CAP).
2024-06-11 English
Proposed issue of securities - IIQ 6 pages 21.2KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard ASX announcement for a proposed issue of securities, including details about the number and type of securities, issue price, conditions, and timetable. It is focused on a placement or other type of issue of shares and options. There are no financial statements or performance data, nor is it a report or presentation. The document is a regulatory announcement about capital raising activities and changes in capital structure. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief notice or a report publication announcement but a full announcement of a capital raising event.
2024-06-11 English
Update - Proposed issue of securities - IIQ 6 pages 21.1KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and contains detailed information about a proposed securities issue by INOVIQ LTD, including the number and type of securities, issue price, conditions, timetable, and regulatory compliance with ASX Listing Rules. It is an update to a previous announcement regarding the expiry date of options attached to the securities. The content focuses on the company's capital raising activities and the issuance of new shares and options. There are no financial statements or earnings data, nor is this a report or presentation. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2024-06-11 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.